Delivery Order SPE2DB22D2206-SPE2DB25FHK23

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $9.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,188.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Taltz 80 mg/ml autoinjectors. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order, valued at $15,649.25, is for the supply of Taltz 80 mg/mL autoinjectors in a 3-pack to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,158.43, is for the procurement of Taltz 80 mg/mL autoinjectors. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $2,179.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, with a performance period through June 16, 2025. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Taltz 80 mg/mL autoinjectors. The $8,935.93 contract has an ultimate completion date of August 13, 2024. It is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its extensive supply chain network, provides a wide range of pharmaceutical and medical products to support various government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,971.93 firm-fixed-price delivery order is for the supply of the specialty medication Taltz 80 mg/mL autoinjector. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Taltz 80 mg/mL autoinjectors. The $12,108.79 award has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc., which does business as Amerisourcebergen. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,886.05, is for the delivery of Taltz 80 mg/mL autoinjectors (2-pack) to support military and federal healthcare programs. The contract is a firm fixed-price delivery order, with a completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $12,169.68 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a specialty medication, with a performance period through March 27, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,700.44, is for the procurement of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHK23
    Delivery Order

This is a $9,478.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Taltz 80 mg/ml autoinjectors (2-pack) and does not have a set-aside designation, indicating open competition.

Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 9/10/25, 9:57 AM